Abstract
Failing hearts of dilated cardiomyopathy (DCM)-patients reveal systolic dysfunction and upregulation of several Protein Kinase C (PKC) isoforms. Recently, we demonstrated that the functional effects of T204E, a PKC phosphomimic of cardiac troponin T (TnT), were differently modulated by α- and β-myosin heavy chain (MHC) isoforms. Therefore, we hypothesized that the interplay between the effects of T204E and a DCM-linked mutation (K211Δ or R206W) in TnT would modulate contractile parameters linked-to systolic function in an MHC-dependent manner. To test our hypothesis, five TnT variants (wildtype, K211Δ, K211Δ + T204E, R206W, and R206W + T204E) were generated and individually reconstituted into demembranated cardiac muscle fibers from normal (α-MHC) and propylthiouracil-treated (β-MHC) rats. Steady-state and mechano-dynamic measurements were performed on reconstituted fibers. Myofilament Ca2+ sensitivity (pCa50) was decreased by both K211Δ and R206W to a greater extent in α-MHC fibers (~0.15 pCa units) than in β-MHC fibers (~0.06 pCa units). However, T204E exacerbated the attenuating influence of both mutants on pCa50 only in β-MHC fibers. Moreover, the magnitude of muscle length (ML)-mediated crossbridge (XB) recruitment was decreased by K211Δ + T204E (~47 %), R206W (~34 %), and R206W + T204E (~36 %) only in β-MHC fibers. In relevance to human hearts, which predominantly express β-MHC, our data suggest that the interplay between the effects of DCM mutations, PKC phosphomimic in TnT, and β-MHC lead to systolic dysfunction by attenuating pCa50 and the magnitude of ML-mediated XB recruitment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bowling N et al (1999) Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart. Circulation 99:384–391. doi:10.1161/01.CIR.99.3.384
Campbell K (1997) Rate constant of muscle force redevelopment reflects cooperative activation as well as cross-bridge kinetics. Biophys J 72:254–262. doi:10.1016/S0006-3495(97)78664-8
Campbell KB, Chandra M (2006) Functions of stretch activation in heart muscle. J Gen Physiol 127:89–94. doi:10.1085/jgp.200509483
Campbell KB, Chandra M, Kirkpatrick RD, Slinker BK, Hunter WC (2004) Interpreting cardiac muscle force-length dynamics using a novel functional model. Am J Physiol Heart Circ Physiol 286:H1535–H1545. doi:10.1152/ajpheart.01029.2003
Chandra M, Tschirgi ML, Rajapakse I, Campbell KB (2006) Troponin T modulates sarcomere length-dependent recruitment of cross-bridges in cardiac muscle. Biophys J 90:2867–2876. doi:10.1529/biophysj.105.076950
Chandra M, Tschirgi ML, Ford SJ, Slinker BK, Campbell KB (2007) Interaction between myosin heavy chain and troponin isoforms modulate cardiac myofiber contractile dynamics. Am J Physiol Regul Integr Comp Physiol 293:R1595–R1607. doi:10.1152/ajpregu.00157.2007
Du CK et al (2007) Knock-in mouse model of dilated cardiomyopathy caused by troponin mutation. Circ Res 101:185–194. doi:10.1161/CIRCRESAHA.106.146670
Fabiato A, Fabiato F (1979) Calculator programs for computing the composition of the solutions containing multiple metals and ligands used for experiments in skinned muscle cells. J Physiol (Paris) 75:463–505
Fitzsimons DP, Patel JR, Moss RL (1998) Role of myosin heavy chain composition in kinetics of force development and relaxation in rat myocardium. J Physiol 513:171–183. doi:10.1111/j.1469-7793.1998.171by.x
Ford SJ, Chandra M, Mamidi R, Dong W, Campbell KB (2010) Model representation of the nonlinear step response in cardiac muscle. J Gen Physiol 136:159–177. doi:10.1085/jgp.201010467
Gollapudi SK, Mamidi R, Mallampalli SL, Chandra M (2012) The N-terminal extension of cardiac troponin T stabilizes the blocked state of cardiac thin filament. Biophys J 103:940–948. doi:10.1016/j.bpj.2012.07.035
Guo X, Wattanapermpool J, Palmiter KA, Murphy AM, Solaro RJ (1994) Mutagenesis of cardiac troponin I. Role of the unique NH2-terminal peptide in myofilament activation. J Biol Chem 269:15210–15216
Herron TJ, Korte FS, McDonald KS (2001) Loaded shortening and power output in cardiac myocytes are dependent on myosin heavy chain isoform expression. Am J Physiol Heart Circ Physiol 281:H1217–H1222
Hershberger RE et al (2009) Clinical and functional characterization of TNNT2 mutations identified in patients with dilated cardiomyopathy. Circ Cardiovasc Genet 2:306–313. doi:10.1161/CIRCGENETICS.108.846733
Huxley AF (1957) Muscle structure and theories of contraction. Prog Biophys Biophys Chem 7:255–318
Inoue T et al (2013) Depressed Frank-Starling mechanism in the left ventricular muscle of the knock-in mouse model of dilated cardiomyopathy with troponin T deletion mutation DeltaK210. J Mol Cell Cardiol 63:69–78. doi:10.1016/j.yjmcc.2013.07.001
Jin JP, Chong SM (2010) Localization of the two tropomyosin-binding sites of troponin T. Arch Biochem Biophys 500:144–150. doi:10.1016/j.abb.2010.06.001
Kamisago M et al (2000) Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 343:1688–1696. doi:10.1056/NEJM200012073432304
Kobayashi M, Debold EP, Turner MA, Kobayashi T (2013) Cardiac muscle activation blunted by a mutation to the regulatory component, troponin T. J Biol Chem 288:26335–26349. doi:10.1074/jbc.M113.494096
Liu B, Lopez JJ, Biesiadecki BJ, Davis JP (2014) Protein kinase C phosphomimetics alter thin filament Ca2+ binding properties. PLoS One 9:e86279. doi:10.1371/journal.pone.0086279
Mamidi R, Chandra M (2013) Divergent effects of α- and β-myosin heavy chain isoforms on the N terminus of rat cardiac troponin T. J Gen Physiol 142:413–423. doi:10.1085/jgp.201310971
Mamidi R, Michael JJ, Muthuchamy M, Chandra M (2013) Interplay between the overlapping ends of tropomyosin and the N terminus of cardiac troponin T affects tropomyosin states on actin. FASEB J 27:3848–3859. doi:10.1096/fj.13-232363
Manning EP, Tardiff JC, Schwartz SD (2011) A model of calcium activation of the cardiac thin filament. Biochemistry 50:7405–7413. doi:10.1021/bi200506k
Metzger JM, Wahr PA, Michele DE, Albayya F, Westfall MV (1999) Effects of myosin heavy chain isoform switching on Ca2+-activated tension development in single adult cardiac myocytes. Circ Res 84:1310–1317. doi:10.1161/01.RES.84.11.1310
Michael JJ, Chandra M (2015) Functional effects of the H1-helix of rat cardiac troponin T on crossbridge detachment rate is differently modulated by α- and β-myosin heavy chain isoforms. Biophys J 108:p596a. doi:10.1016/j.bpj.2014.11.3245
Michael JJ, Chandra M (2016) Interplay between the effects of dilated cardiomyopathy mutation (R206L) and the protein kinase C phosphomimic (T204E) of rat cardiac troponin T are differently modulated by α- and β-myosin heavy chain isoforms. J Am Heart Assoc. doi:10.1161/JAHA.115.002777
Michael JJ, Gollapudi SK, Ford SJ, Kazmierczak K, Szczesna-Cordary D, Chandra M (2012) Deletion of 1-43 amino acids in cardiac myosin essential light chain blunts length dependency of Ca2+ sensitivity and crossbridge detachment kinetics. Am J Physiol Heart Circ Physiol 304:H253–H259. doi:10.1152/ajpheart.00572.2012
Michael JJ, Gollapudi SK, Chandra M (2014) Effects of pseudo-phosphorylated rat cardiac troponin T are differently modulated by α- and β-myosin heavy chain isoforms. Basic Res Cardiol 109:442. doi:10.1007/s00395-014-0442-9
Mirza M et al (2005) Dilated cardiomyopathy mutations in three thin filament regulatory proteins result in a common functional phenotype. J Biol Chem 280:28498–28506. doi:10.1074/jbc.M412281200
Mogensen J et al (2004) Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 44:2033–2040. doi:10.1016/j.jacc.2004.08.027
Morimoto S et al (2002) Ca(2+)-desensitizing effect of a deletion mutation Delta K210 in cardiac troponin T that causes familial dilated cardiomyopathy. Proc Natl Acad Sci USA 99:913–918. doi:10.1073/pnas.022628899
Otten E et al (2010) Recurrent and founder mutations in the Netherlands: mutation p. K217del in troponin T2, causing dilated cardiomyopathy. Neth Heart J 18:478–485. doi:10.1007/bf03091819
Pan BS, Johnson RG Jr (1996) Interaction of cardiotonic thiadiazinone derivatives with cardiac troponin C. J Biol Chem 271:817–823. doi:10.1074/jbc.271.2.817
Razumova MV, Bukatina AE, Campbell KB (2000) Different myofilament nearest-neighbor interactions have distinctive effects on contractile behavior. Biophys J 78:3120–3137. doi:10.1016/S0006-3495(00)76849-4
Reiser PJ, Kline WO (1998) Electrophoretic separation and quantitation of cardiac myosin heavy chain isoforms in eight mammalian species. Am J Physiol 274:H1048–H1053
Robinson P, Griffiths PJ, Watkins H, Redwood CS (2007) Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments. Circ Res 101:1266–1273. doi:10.1161/CIRCRESAHA.107.156380
Schlecht W, Zhou Z, Li KL, Rieck D, Ouyang Y, Dong WJ (2014) FRET study of the structural and kinetic effects of PKC phosphomimetic cardiac troponin T mutants on thin filament regulation. Arch Biochem Biophys 550–551:1–11. doi:10.1016/j.abb.2014.03.013
Sfichi-Duke L et al (2010) Cardiomyopathy-causing deletion K210 in cardiac troponin T alters phosphorylation propensity of sarcomeric proteins. J Mol Cell Cardiol 48:934–942. doi:10.1016/j.yjmcc.2010.01.005
Simonis G, Briem SK, Schoen SP, Bock M, Marquetant R, Strasser RH (2007) Protein kinase C in the human heart: differential regulation of the isoforms in aortic stenosis or dilated cardiomyopathy. Mol Cell Biochem 305:103–111. doi:10.1007/s11010-007-9533-3
Stelzer JE, Larsson L, Fitzsimons DP, Moss RL (2006) Activation dependence of stretch activation in mouse skinned myocardium: implications for ventricular function. J Gen Physiol 127:95–107. doi:10.1085/jgp.200509432
Sumandea MP, Pyle WG, Kobayashi T, de Tombe PP, Solaro RJ (2003) Identification of a functionally critical protein kinase C phosphorylation residue of cardiac troponin T. J Biol Chem 278:35135–35144. doi:10.1074/jbc.M306325200
Takeda S, Yamashita A, Maeda K, Maeda Y (2003) Structure of the core domain of human cardiac troponin in the Ca(2+)-saturated form. Nature 424:35–41. doi:10.1038/nature01780
Tardiff JC et al (1998) A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy. J Clin Invest 101:2800–2811. doi:10.1172/JCI2389
Tschirgi ML, Rajapakse I, Chandra M (2006) Functional consequence of mutation in rat cardiac troponin T is affected differently by myosin heavy chain isoforms. J Physiol 574:263–273. doi:10.1113/jphysiol.2006.107417
Acknowledgments
This work was supported, in part, by a grant from the National Heart, Lung, and Blood Institute. Grant # (R01-HL-075643) to Murali Chandra and a Poncin Fellowship to John Jeshurun Michael. The authors declare no competing financial interests. The authors would like to acknowledge Sherif Reda for his assistance in protein purification.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Michael, J.J., Gollapudi, S.K. & Chandra, M. Interplay between the effects of a Protein Kinase C phosphomimic (T204E) and a dilated cardiomyopathy mutation (K211Δ or R206W) in rat cardiac troponin T blunts the magnitude of muscle length-mediated crossbridge recruitment against the β-myosin heavy chain background. J Muscle Res Cell Motil 37, 83–93 (2016). https://doi.org/10.1007/s10974-016-9448-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10974-016-9448-2